# Radiomics for Prediction of Survival in GBM

> **NCT02666066** · — · COMPLETED · sponsor: **Maastricht Radiation Oncology** · enrollment: 289 (actual)

## Conditions studied

- Glioblastoma
- Glioma
- Astrocytoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02666066
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-07
- **Target enrollment:** 289 (ACTUAL)
- **Last updated:** 2018-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02666066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02666066, "Radiomics for Prediction of Survival in GBM". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02666066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*